MedPath

A Study to Determine the Frequency and Risk Factors on the Formation of New Antibodies Against Red Cell Antigen Following Transfusion.

Not Applicable
Conditions
Health Condition 1: R768- Other specified abnormal immunological findings in serum
Registration Number
CTRI/2024/01/061412
Lead Sponsor
MAHE MANIPA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Recipients of blood transfusion for the requests received In the Department of Immunohematology and blood transfusion within Kasturba Hospital, Manipal

Exclusion Criteria

Recipients of red cell transfusion from outside hospitals other than KH, Manipal

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)the prevalence of red cell alloimmunization in the recipient’s blood before transfusion. <br/ ><br> <br/ ><br>2)identify the risk factors associated with red cell alloimmunization & in turn develop strategies to prevent alloimmunization.Timepoint: Assessment will be at the Baseline.
Secondary Outcome Measures
NameTimeMethod
identify the risk factors associated with red cell alloimmunization & in turn develop strategies to prevent alloimmunization.Timepoint: Assessment will be at the Baseline.
© Copyright 2025. All Rights Reserved by MedPath